Hydrogen Peroxide Content and pH of Expired Breath Condensate from Patients with Asthma and COPD. (1st February 2014)

• Record Type: Journal Article
• Authors: Murata, Kazuya; Fujimoto, Keisaku; Kitaguchi, Yoshiaki; Horiuchi, Toshimichi; Kubo, Keishi; Honda, Takayuki
• Is Part Of: COPD. Volume 11:Number 1(2014:Feb.)
• Page Start: 81
• Page End: 87
• Publication Date: 2014-02-01
• Subjects: Lungs -- Diseases, Obstructive -- Periodicals; 616.24
• DOI: 10.3109/15412555.2013.830094
• Languages: English
• ISSNs: 1541-2555

Abstract

<abstract> <title>Abstract</title> <p> <italic>Background:</italic> Oxidative stress is implicated in the pathogenesis of asthma and chronic obstructive pulmonary disease (COPD). Analysis of the expired breath condensate (EBC) has been suggested to provide non-invasive inflammatory markers that reflect oxidative stress in the airways. <italic>Objective:</italic> The present study attempts to elucidate whether the hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) levels and pH values in EBC may be useful as biomarkers of the activity or severity of asthma and COPD. <italic>Methods:</italic> We measured the H<sub>2</sub>O<sub>2</sub> levels and pH values using a derivatives of reactive oxygen metabolites exhalation test kit (Diacron) and a pH analyser, respectively, in EBC obtained using an EcoScreen from 29 patients with asthma, 33 with COPD, and 33 healthy individuals (all non-smokers). We then examined the relationships among oxidative stress and the asthma control test (ACT) or COPD assessment test (CAT) scores, pulmonary function, fractional exhaled nitric oxide (FeNO), and the extent of low attenuation areas on HRCT. <italic>Results:</italic> The H<sub>2</sub>O<sub>2</sub> levels were elevated and pH was lower in both asthma (H<sub>2</sub>O<sub>2</sub>; 8.75 ± 0.88 μM, <italic>p</italic> < 0.01, pH; 7.14 ± 0.07, <italic>p</italic> < 0.05) and COPD (H<sub>2</sub>O<sub>2</sub>; 7.44 ± 0.89 μM, <italic>p</italic> < 0.01, pH; 6.87 ± 0.10, <italic>p</italic> < 0.01) compared with control subjects (H<sub>2</sub>O<sub>2</sub>; 3.42 ± 0.66 μM, pH; 7.35 ± 0.04). Neither the H<sub>2</sub>O<sub>2</sub> levels nor pH correlated with the ACT scores and FeNO in asthma patients. Neither the H<sub>2</sub>O<sub>2</sub> levels nor pH significantly correlated with the pulmonary function in asthma and COPD. However, the CAT scores significantly correlated with the H<sub>2</sub>O<sub>2</sub> levels in patients with COPD (r = 0.52, <italic>p</italic> < 0.01). <italic>Conclusions:</italic> These findings suggest that oxidative stress is involved in the pathogenesis of asthma and COPD and that the H<sub>2</sub>O<sub>2</sub> levels in EBC might reflect the health status in COPD.</p> </abstract>